Firm News

Ovarian Cancer Drug Doxil Shortage To Ease By End of 2012 J & J Claims


Posted on Jan 30, 2012

The long-running shortage of the ovarian cancer drug Doxil should ease by the end of 2012 says Johnson & Johnson, according to a report in the St. Paul Pioneer Press, "As Shortages Increase, Drugmakers Feel the Heat." 

Read More About Ovarian Cancer Drug Doxil Shortage To Ease By End of 2012 J & J Claims...

back to top


©2012 Robert Abell Law, All Rights Reserved, Reproduced with Permission Privacy Policy
Attorney web design by Foster Web Marketing, the best attorney website design solution on the Web offering search engine optimization for attorneys, lawyer website design, video for attorneys, and more.
Get SEO Tips from The Attorney Internet Marketing Blog